Bristol Myers Squibb to buy Karuna Therapeutics for $14 billion in cash

Bristol Myers CEO on Biontech deal: Next new frontier in treatment of cancer

WBD CEO David Zaslav made an ‘incredible’ decision to split the company: LightShed’s Rich Greenfield

Demand for AI infrastructure has been relentless, says CoreWeave CEO Mike Intrator

Treating Schizophrenia with Muscarinic Antipsychotics | Steve Paul

Private Credit Default Rates Could Hit 15%, UBS Warns

We got a number of important drugs from the Celgene acquisition, says Bristol Myers Squibb CEO

The Banks Have ‘Lost Control’: $300 Silver, India’s Bid & the End of Western Pricing - Eric Sprott

Почему Nike испытывает трудности

Paramount win? Netflix drops out of WBD bidding war

Zscaler CEO Jay Chaudhry: 'For every employee, there will be 50 to 100 AI agents'

What's the 'New Sanofi' Like? Let CEO Paul Hudson Explain. | At Barron's

Brace for Volatile End to February, CRWV Collapses & XYZ Slashes Workforce

Media Mogul Tom Rogers: Netflix has a great path ahead after freeing itself from Warner Bros. deal

Why Nike could be poised for a turnaround

What's driving the decline in Canada's GDP in Q4

Steve Barton: Gold, Silver Price Targets, Plus New Opportunity I Like

Blackrock's 2026 Warning: "The Retirement Crisis No One Is Ready For"

Strong consumer holds up economy as markets split and AI reshapes jobs

Charlie Munger: How to Build Assets that Pay You FOREVER

3 High Yield Dividends Stocks (+7% Yields!) Rated Strong Buys, And UNDER $30 a Share! Time to BUY?!